University of Wisconsin Foundation

Key Holdings

The portfolio is dominated by two top positions that together command over 50% of the total assets. Pearl Diver Credit Company I is the largest holding at $24.07 million (26.16%), followed closely by NU Hldgs Ltd at $22.93 million (24.91%). These two "Unknown" classification assets provide a substantial base for the portfolio.

The remaining exposure is heavily tilted toward high-growth, speculative biotechnology. Akero Therapeutics (AKRO) represents the third-largest position at $15.60 million (16.95%), followed by Avidity Biosciences (RNA) at $12.60 million (13.69%). Notably, the portfolio includes a major position in Nvidia (NVDA) at $10.27 million (11.17), serving as the primary technology holding. Dyne Therapeutics (DYN) rounds out the list with a 7.12% allocation. The heavy weighting in biotech names like AKRO, RNA, and DYN suggests a risk-tolerant approach seeking asymmetric returns from clinical-stage companies.